New drug duo tested in fight against returning bone cancer
NCT ID NCT04417062
Summary
This study is testing whether combining two drugs, olaparib and ceralasertib, can help control osteosarcoma (a type of bone cancer) that has come back or stopped responding to standard treatments. It is for patients aged 12 to 40. The main goal is to see if this combination can stop the cancer from progressing for a meaningful period of time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institite
Boston, Massachusetts, 02115, United States
-
MD Anderson
Houston, Texas, 77030, United States
-
Memorial Sloan Kettering
New York, New York, 10065, United States
-
UCSF Benioff Children's Hospital; UCSF Pediatrics Hematology Oncology
San Francisco, California, 94158, United States
Conditions
Explore the condition pages connected to this study.